Globenewswire

Search documents
ATARI: Capital increase in relation to the repayment in shares of loans from IRATA LLC
Globenewswire· 2025-08-07 16:00
Capital increase in relation to the repayment in shares of loans from IRATA LLC PARIS, FRANCE (August 7, 2025 - 6.00 pm CET) - Atari® (Euronext Growth Paris: ALATA) — one of the world's most iconic consumer brands and interactive entertainment producers — today announces the repayment of€13.9 million loans previously granted to Atari SA by Irata LLC, the holding company of Wade Rosen, Chairman and Chief Executive Officer of Atari SA, through a capital increase reserved to IRATA LLC. The repayment in Atari SA ...
Fly Play hf.: Financial Results Q2 2025
Globenewswire· 2025-08-07 15:52
Fly Play hf.: Financial Results Q2 2025 Business plan on track by focusing on leisure routes, profit-driven network planning, and securing long-term ACMI agreements. Strong operations in Q2, with higher TRASK and lower adjusted CASK, though adverse FX movements and maintenance delay costs impacted results. Cash at the end of Q2 stood at USD 11.9 million, including restricted cash. PLAY has secured subscription commitments totalling USD 20 million (ISK 2.4 billion), expected to be finalised by mid-August, ...
CANCELS AND REPLACES _ PR_Tarkett - 2025 Half year Financial report available
Globenewswire· 2025-08-07 15:48
PARIS, FRANCE, August 07th, 2025 - Financial Report for First half Fiscal 2025 available The Financial report for the First half Fiscal 2025 is available online and filed with the Autorité des marchés financiers (AMF). This document is available on Tarkett’s website, www.tarkett-group.com, under section “Investors”. It includes the condensed consolidated financial statements for the first half of Fiscal 2025, the First half activity report, the statement of responsibility for the First half financial repor ...
Dorel Provides Update on Long-Term Debt
Globenewswire· 2025-08-07 15:33
MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced that on August 7, 2025, it again amended its asset backed loan (ABL) facility and term loan facility whereby Dorel’s lenders agreed to continue to forebear from enforcing their rights and exercising their remedies under both the ABL facility and term loan facility further to a default by Dorel relating to certain financial covenants. The initial forbearance period commenced on May 9, 2025 and has now been e ...
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
Globenewswire· 2025-08-07 15:30
Press Release – No. 11 / 2025 Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results Copenhagen, Denmark, August 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on August 14, 2025, at 2:00 pm CET (8:00 am ET) following the announcement of financial results for the second quart ...
Gray Media and Graham Media Group Raise More Than $1.1 Million Dollars for Texas Flooding Relief
Globenewswire· 2025-08-07 15:30
ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Gray Media and Graham Media Group announced today their joint fundraiser, Together for Texas, has generated more than $1,104,000 for the Central Texas and the Hill Country communities affected by devastating flooding on July 4th. In the days immediately following the tragedy, Gray stations across 113 markets and Graham Media Group’s KSAT in San Antonio and KPRC in Houston launched the campaign encouraging support for The Salvation Army’s relief efforts in the regi ...
Vaisala Corporation: Share Repurchase 7.8.2025
Globenewswire· 2025-08-07 15:30
VAISALA CORPORATIONSTOCK EXCHANGE RELEASE 7.8.2025 Vaisala Corporation: Share Repurchase 7.8.2025 In the Helsinki Stock Exchange Trade date 7.8.2025 Bourse trade Buy Share VAIAS Amount 2 000SharesAverage price/ share 46,7738EURTotal cost 93 547,60EUR Vaisala Corporation now holds a total of 133 629 shares<td colspan="2" ...
UNTOLD Romania 期间,Bitget 以 ₿itopia 将心跳化作艺术之美
Globenewswire· 2025-08-07 15:22
克卢日--纳波卡,罗马尼亚, Aug. 07, 2025 (GLOBE NEWSWIRE) -- 8 月 7 日至 11 日,全球领先的加密货币交易所和 Web3 公司 Bitget 将在罗马尼亚 UNTOLD X 音乐节上展示 360° 互动式数字装置——₿itopia: #FeelThe₿eat。 本次体验将融合 UNTOLD 享誉盛名的宏大舞台与全新互动艺术形式,巧妙结合加密货币、创意与社区的力量。 该装置以 Bitget 的吉祥物 Bunz 为核心,中央矗立着一尊大型吉祥物雕塑。 Bunz 环绕着 ₿itopia 中心的 360° 镜面圣所,邀您步入一个兼具雕塑艺术与沉浸体验的奇妙空间。 白昼时分,它映照着四周森林;入夜之后,它化作一幅生动的画布,随着互动光影与声响灵动绽放。 访客可以步入 Bunz 的心脏,触发生物心跳传感器,将脉搏信号注入由 AI 生成、实时绽放演变的数字花海。 这是一幅由想象力、生物律动与区块链技术交织而成的共享织锦,映照着每个人独特的当下体验。 #FeelThe₿eat,化身艺术。 雕塑周围,“梦想之墙” (Wall of Dreams) 环绕,白日以光为笔,写下回应者的心 ...
澳大利亚内政部批准 Prometric 的 CELPIP 考试
Globenewswire· 2025-08-07 15:14
这为国际申请者提供了一个满足签证语言要求的新选择巴尔的摩, Aug. 07, 2025 (GLOBE NEWSWIRE) -- 资格认证与技能发展领域的全球领导者 Prometric 今日宣布,其综合英语语言能力评估工具 CELPIP 测试现已获得澳大利亚政府官方认可,测试成绩可用于申请签证。 内政部已将 CELPIP 加入其认可的英语语言能力测试名单,为国际学生和求职者提供了经过科学验证且受政府背书的可靠新选择,方便他们在申请过程中证明其英语技能。 CELPIP 最初由英属哥伦比亚大学的语言专家开发,用于加拿大的移民、公民身份申请及职业认证,现已在更多领域广泛使用。 测试评估四项重要语言技能:听力、阅读、写作、口语。 考试在 3 小时内一次性完成,为考生带来更简洁顺畅的体验。 还在线提供各种官方备考资料和模拟测试,帮助考生充分准备、信心迎考。 随着 CELPIP 获得澳大利亚签证认可,Prometric 也在推进其使命:通过扩大全球对可靠、公平评估的获取渠道,帮助个人开启新的职业与生活机会,助力未来人才队伍的建设。 测试已推向 30 多个市场,包括澳大利亚、中国、印度和菲律宾的重要城市,方便考生获得可靠、优 ...
Genmab Announces Financial Results for the First Half of 2025
Globenewswire· 2025-08-07 15:08
Core Insights - Genmab has made significant progress in its strategic priorities, focusing on expanding access to innovative therapies and maximizing the potential of its commercialized medicines [2] - The company has updated its revenue and operating profit guidance for 2025, driven by increased royalty revenues from DARZALEX [4] Financial Performance - Revenue for the first half of 2025 reached $1,640 million, a 19% increase from $1,382 million in the same period of 2024, primarily due to higher royalties from DARZALEX and Kesimpta, as well as increased EPKINLY net product sales [6][7] - Royalty revenue was $1,378 million in the first half of 2025, up 24% from $1,111 million in the first half of 2024, attributed to higher net sales of DARZALEX and Kesimpta [7] - Operating profit for the first half of 2025 was $548 million, compared to $352 million in the first half of 2024 [7] 2025 Full Year Outlook - Revised revenue guidance for 2025 is set between $3,500 million and $3,700 million, with a midpoint of $3,600 million, an increase from the previous guidance of $3,340 million to $3,660 million [5] - Royalties are expected to be between $2,945 million and $3,090 million, with a midpoint of $3,017 million, up from the previous guidance of $2,785 million to $3,015 million [5] - Net product sales/collaboration revenue is projected to be between $425 million and $465 million, with a midpoint of $445 million [5] Pipeline Developments - Epcoritamab is advancing to earlier lines of therapy with a supplemental Biologics License Application (sBLA) submitted to the FDA for use in patients with relapsed or refractory follicular lymphoma [6] - Rina-S continues to show promising antitumor activity in endometrial cancer, with data presented at the 2025 ASCO Annual Meeting [6] Other Matters - Genmab has changed its functional currency and presentation currency from DKK to USD effective January 1, 2025, with retrospective adjustments made to prior periods [9]